Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Circassia Pharmaceuticals ( (GB:NIOX) ) has provided an announcement.
NIOX Group plc has applied to the London Stock Exchange for a block admission of 4,919,318 ordinary shares of 0.08 pence each to be admitted to trading on AIM. The new shares will be issued over time upon exercise of options granted under the company’s 2023 Performance Share Plan, providing capacity to satisfy future employee equity awards.
Admission of the block-listed shares is expected to become effective on 20 March 2026, with the new stock ranking pari passu with existing ordinary shares. The move supports the company’s long-term incentive arrangements without an immediate dilutive fundraising, aligning employee incentives with shareholder interests while maintaining consistency in share rights and market trading.
The most recent analyst rating on (GB:NIOX) stock is a Buy with a £86.00 price target. To see the full list of analyst forecasts on Circassia Pharmaceuticals stock, see the GB:NIOX Stock Forecast page.
Spark’s Take on NIOX Stock
According to Spark, TipRanks’ AI Analyst, NIOX is a Neutral.
Circassia Pharmaceuticals’ overall stock score is driven by its strong financial performance and positive corporate events, which are offset by neutral technical indicators and a high P/E ratio suggesting overvaluation. The company’s robust cash flow and low leverage provide a stable foundation, while recent corporate actions signal confidence in future growth.
To see Spark’s full report on NIOX stock, click here.
More about Circassia Pharmaceuticals
NIOX Group plc is a healthcare company listed on London’s AIM market, focused on respiratory diagnostics. The group develops and supplies medical devices and related technologies used to support the management of respiratory conditions, positioning it within the wider medtech and life sciences sector.
Average Trading Volume: 684,748
Technical Sentiment Signal: Sell
Current Market Cap: £251.6M
See more insights into NIOX stock on TipRanks’ Stock Analysis page.